-1.4 (-2.31%)
-1.3 (-2.14%) 4.01 pm | 13 Feb 2012 | Source: Moneycontrol.com
Dolat Capital is bullish on Dishman Pharma and has recommended accumulate rating on the stock with a target of Rs 64 in its February 10, 2012 research...
6.04 pm | 09 Feb 2012 | Source: CNBC-TV18
SP Tulsian, sptulsian.com is negative on tyre stocks. ...
4.46 pm | 09 Feb 2012 | Source: CNBC-TV18
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com analyses select stocks such as Gati, Dishman Pharma, Apollo Tyres, Dhanlaxmi Bank, infrastru...
2.50 pm | 09 Feb 2012 | Source: CNBC-TV18
Managing director of Dishman Pharma tells CNBC-TV18 that higher earnings from its contract revenue business is what led to the surge in third quarter ...
2.44 pm | 19 Jan 2012 | Source: CNBC-TV18
Dishman Pharmaceuticals and Chemicals' subsidiary Carbogen Amcis AG has acquired Creapharm Parenterals. In an interview to CNBC-TV18, VVS Murthy, chie...
1.37 pm | 14 Jan 2012 | Source: Moneycontrol.com
Pharmaceutical companies are expected to report healthy 15-25% year-on-year revenue growth in the third quarter, helped by new launches especially in ...
6.20 pm | 11 Jan 2012 | Source: Moneycontrol.com
KRChoksey has come with its December quarterly earning estimates for Pharma sector. According to the research firm, Q3FY12 is expected to be a strong ...
6.34 pm | 10 Jan 2012 | Source: Moneycontrol.com
Emkay Global Financial Services has come with its December quarterly earning estimates for pharmaceutical sector. According to the research firm the s...
3.40 pm | 21 Nov 2011 | Source: Moneycontrol.com
Angel Broking is bullish on Dishman Pharmaceuticals and has recommended buy rating on the stock with a target price of Rs 68 in its November 16, 2011 ...
4.05 pm | 17 Nov 2011 | Source: CNBC-TV18
Managing director of Dishman Pharmaceuticals, JR Vyas expects the topline growth to be 15% or even more going forward. He also added that the bottomli...
4.00 pm | 15 Oct 2011 | Source: Moneycontrol.com
KR Choksey has come out with its earning estimates on Pharma sector for the quarter ended September 2011. According to the research firm, Dishman Phar...
11.46 am | 11 Oct 2011 | Source: Moneycontrol.com
Dolat Capital has come out with its earning estimates on Pharma sector for the quarter ended September 2011. According to the research firm, Dishman S...
|
| Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
Bigg Boss Season 5
| History India | Davos
| DLF | Sun Pharma | Rafale | Mahindra Satyam | BSE Sensex | Organisation for Economic Co-operation and Development | Reliance Power | Vadodara | State Bank of India | Petroleum